Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?

Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study

  1. Jeannette Lee, MBBS1,
  2. Stefan Ma, PHD2,
  3. Derrick Heng, MBBS2,
  4. Chee-Eng Tan, PHD3,
  5. Suok-Kai Chew, MSC2,
  6. Kenneth Hughes, DM1 and
  7. E-Shyong Tai, MB, CHB4
  1. 1Department of Community, Occupational and Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  2. 2Ministry of Health, Singapore
  3. 3Center for Molecular Epidemiology, Faculty of Medicine, National University of Singapore, Singapore
  4. 4Department of Endocrinology, Singapore General Hospital, Singapore
  1. Address correspondence and reprint requests to Jeannette Lee, Community, OccupationalFamily Medicine, Yong Loo Lin School of Medicine, MD3, National University of Singapore, 16 Medical Dr., Singapore, 117597. E-mail: cofleejm{at}nus.edu.sg

Abstract

OBJECTIVE—The International Diabetes Federation (IDF) proposes that central obesity is an “essential” component of the metabolic syndrome, while the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) proposes that central obesity is an “optional” component. This study examines the effect of the metabolic syndrome with and without central obesity in an Asian population with ischemic heart disease (IHD).

RESEARCH DESIGN AND METHODS—From the population-based cohort study (baseline 1992–1995), 4,334 healthy individuals were grouped by the presence or absence of the metabolic syndrome and central obesity and followed up for an average of 9.6 years by linkage with three national registries. Cox’s proportional hazards model was used to obtain adjusted hazard ratios (HRs) for risk of a first IHD event.

RESULTS—The prevalence of metabolic syndrome was 17.7% by IDF criteria and 26.2% by AHA/NHLBI criteria using Asian waist circumference cutoff points for central obesity. Asian Indians had higher rates than Chinese and Malays. There were 135 first IHD events. Compared with individuals without metabolic syndrome, those with central obesity/metabolic syndrome and no central obesity/metabolic syndrome were at significantly increased risk of IHD, with adjusted HRs of 2.8 (95% CI 1.8–4.2) and 2.5 (1.5–4.0), respectively.

CONCLUSIONS—Having metabolic syndrome either with or without central obesity confers IHD risk. However, having central obesity as an “optional” rather than “essential” criterion identifies more individuals at risk of IHD in this Asian cohort.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted November 14, 2006.
    • Received September 7, 2006.
« Previous | Next Article »Table of Contents

This Article

  1. doi: 10.2337/dc06-1866 Diabetes Care February 2007 vol. 30 no. 2 343-347
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)

Current Issue

  1. December 2009, 32 (12)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care